Akershus University Hospital to Present Poster of Pre Diagnostic’s Immunoassay at AAIC 2020
Akershus University Hospital, Pre Diagnostics scientific partner, presents its poster “A new biological assay measuring Aβ clearance -the Aβ mid-domain immunoassay” at the Alzheimer’s Association International Conference (AAIC) on July 27-31, 2020. The poster discloses details on the development of Pre Diagnostic’s mid-domain Aβ immunoassay and suggests that the test may be useful for measuring disease progression and intervention studies. The AAIC is the world’s largest international conference in the dementia field.
Pre Diagnostics first Research Use Only (RuO) assay
The first version of the data sheet for new Simoa assay for quantitating intracellular Beta Amyloid mid domain peptides in monocytes from peripheral blood is now available
A new blood-based biomarker of Aβ clearance
PreDiagnostics published two posters from its work called “A new blood-based biomarker of Aβ clearance – the monocyte Aβ mid-domain assay” and “Assessing Aβ clearance aided by mass spectrometry” at the Clinical Trials on Alzheimer’s Disease Conference in December 2019.